Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials
- PMID: 19850901
- PMCID: PMC2791930
- DOI: 10.3324/haematol.2009.009696
Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials
Abstract
Background: Although widely recommended, cryopreservation of sperm is sometimes not performed for patients with Hodgkin's lymphoma because of presumed poor sperm quality related to the disease. We investigated sperm quality and factors determining it in untreated patients with early stage Hodgkin's lymphoma.
Design and methods: Of 2362 males who participated in EORTC H6-H9 trials, 474 (20%) had data available. Sperm quality was defined according to World Health Organization guidelines. Determining factors were studied by logistic regression analysis.
Results: The median sperm concentration was 40x10(6)/mL (range, 0-345x10(6)/mL) and the median motility 50% (range, 0-90%). Sperm quality was good (concentration >or=20x10(6)/mL and motility >or=50%), intermediate (concentration >or=5x10(6)/mL) and poor (concentration <5x10(6)/mL but >0) in 41%, 49% and 7% of patients, respectively. Three percent of the patients were azoospermic. No relation was found between sperm quality and age or clinical stage of the Hodgkin's lymphoma, but B-symptoms and elevated erythrocyte sedimentation rate predicted poor sperm quality. The odds ratios for the association of poor sperm quality with the variables examined were: presence of B-symptoms, 2.77 (95% CI, 1.50-5.12; p=0.001); erythrocyte sedimentation rate of 50 mm/h or greater, 2.35 (95% CI, 1.24-4.43; p=0.009); fever, 3.22 (95% CI, 1.41-7.33; p=0.005), and night sweats, 3.78 (95% CI, 1.97-7.26; p<0.001). There was no relation between sperm quality and pre-treatment follicle stimulating hormone level.
Conclusions: In this large study of males with Hodgkin's lymphoma, 90% had good or intermediate sperm quality. Three percent were azoospermic. There was an association between sperm quality and the presence or absence of B-symptoms, in particular fever and night sweats. With modern fertilization techniques, in most patients with early-stage Hodgkin's lymphoma sperm quality before treatment is good enough for future fatherhood.
Figures

Similar articles
-
Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma.Hum Reprod. 1997 Jan;12(1):73-6. doi: 10.1093/humrep/12.1.73. Hum Reprod. 1997. PMID: 9043906
-
Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment.Ann Oncol. 2001 Sep;12(9):1307-11. doi: 10.1023/a:1012464703805. Ann Oncol. 2001. PMID: 11697845
-
Cryopreservation and semen quality in patients with Hodgkin's disease.Cancer. 1995 Jun 1;75(11):2732-6. doi: 10.1002/1097-0142(19950601)75:11<2732::aid-cncr2820751116>3.0.co;2-s. Cancer. 1995. PMID: 7743478
-
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.Ann Oncol. 1998;9 Suppl 5:S147-54. doi: 10.1093/annonc/9.suppl_5.s147. Ann Oncol. 1998. PMID: 9926255 Review.
-
Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.Curr Opin Oncol. 1991 Oct;3(5):843-51. doi: 10.1097/00001622-199110000-00007. Curr Opin Oncol. 1991. PMID: 1751578 Review.
Cited by
-
Evaluation of the azoospermic male.Asian J Androl. 2012 Jan;14(1):82-7. doi: 10.1038/aja.2011.60. Epub 2011 Dec 19. Asian J Androl. 2012. PMID: 22179510 Free PMC article. Review.
-
Effect of the oral intake of astaxanthin on semen parameters in patients with oligo-astheno-teratozoospermia: a randomized double-blind placebo-controlled trial.Radiol Oncol. 2020 Oct 23;55(1):97-105. doi: 10.2478/raon-2020-0062. Radiol Oncol. 2020. PMID: 33885235 Free PMC article. Clinical Trial.
-
Cancer Treatment-Related Infertility: A Critical Review of the Evidence.JNCI Cancer Spectr. 2019 Apr 9;3(1):pkz008. doi: 10.1093/jncics/pkz008. eCollection 2019 Mar. JNCI Cancer Spectr. 2019. PMID: 31360893 Free PMC article. Review.
-
Male Infertility and Reduced Life Expectancy: Epidemiology, Mechanisms, and Clinical Implications.J Clin Med. 2025 Jun 3;14(11):3930. doi: 10.3390/jcm14113930. J Clin Med. 2025. PMID: 40507691 Free PMC article. Review.
-
Oncofertility in Canada: the impact of cancer on fertility.Curr Oncol. 2013 Aug;20(4):e338-44. doi: 10.3747/co.20.1358. Curr Oncol. 2013. PMID: 23904772 Free PMC article.
References
-
- Sieber M, Rueffer U, Josting A, Diehl V. Treatment of Hodgkin’s disease: current strategies of the German Hodgkin’s Lymphoma Study Group. Ann Oncol. 1999;10 (Suppl 6):23–9. - PubMed
-
- Raemaekers J, Kluin-Nelemans H, Teodorovic I, Meerwaldt C, Noordijk E, Thomas J, et al. The achievements of the EORTC Lymphoma Group. European Organization for Research and Treatment of Cancer. Eur J Cancer. 2002;38 (Suppl 4):S107–13. - PubMed
-
- Brusamolino E, Bacigalupo A, Barosi G, Biti G, Gobbi PG, Levis A, et al. Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management and follow-up. Haematologica. 2009;94:550–65. - PMC - PubMed
-
- Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effects of Hodgkin’s disease and combination chemotherapy on gonadal function in the adult male. Cancer. 1982;49:418–22. - PubMed
-
- Viviani S, Ragni G, Santoro A, Perotti L, Caccamo E, Negretti E, et al. Testicular dysfunction in Hodgkin’s disease before and after treatment. Eur J Cancer. 1991;27:1389–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous